Beranda › Penyakit Alzheimer › Florida › Ocala
Uji klinis Penyakit Alzheimer di Ocala, FL
6 studi untuk Penyakit Alzheimer mencari peserta di lokasi sekitar Ocala (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Menerima pesertaFase 2
- Renstar Medical Research, Ocala
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Menerima pesertaFase 3
- Renstar Medical Research, Ocala
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Menerima pesertaFase 3
- Local Institution - 1608, Ocala
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Menerima pesertaFase 2
- Renstar Medical Research ( Site 1012), Ocala
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Menerima pesertaFase 3
- Renstar Medical Research, Ocala
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
Menerima pesertaFase 2
- Renstar Medical Research, Ocala
Uji klinis Penyakit Alzheimer di kota lain
- Boston, MA26 studi
- Orlando, FL25 studi
- St. Louis, MO22 studi
- New York City, NY21 studi
- Miami, FL20 studi
- Tampa, FL17 studi
- Atlanta, GA16 studi
- Philadelphia, PA15 studi
- Phoenix, AZ15 studi
- The Villages, FL15 studi
- Los Angeles, CA14 studi
- Indianapolis, IN14 studi
Studi lain di Ocala
- Kanker Paru Non-Sel Kecil10 studi
- Penyakit Hati Steatotik8 studi
- Obesitas7 studi
- Kelebihan Berat Badan6 studi
- PPOK5 studi
- Gagal Jantung5 studi
- Gangguan Kognitif Ringan3 studi
- Kanker Metastatik3 studi
- Aterosklerosis3 studi
- Penyakit Kardiovaskular3 studi
- Nyeri Kronis3 studi
- Penyakit Hati3 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.